A detailed history of Atika Capital Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Atika Capital Management LLC holds 64,000 shares of NTRA stock, worth $10.4 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
64,000
Previous 30,010 113.26%
Holding current value
$10.4 Million
Previous $3.25 Million 150.35%
% of portfolio
0.93%
Previous 0.39%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$97.75 - $129.67 $3.32 Million - $4.41 Million
33,990 Added 113.26%
64,000 $8.13 Million
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $2.56 Million - $3.38 Million
30,010 New
30,010 $3.25 Million
Q4 2021

Feb 11, 2022

SELL
$86.26 - $119.0 $7.03 Million - $9.7 Million
-81,505 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $1.05 Million - $1.33 Million
-10,495 Reduced 11.41%
81,505 $9.08 Million
Q2 2021

Aug 12, 2021

SELL
$86.05 - $119.72 $1.72 Million - $2.39 Million
-20,000 Reduced 17.86%
92,000 $10.4 Million
Q1 2021

May 14, 2021

SELL
$91.47 - $124.36 $457,350 - $621,800
-5,000 Reduced 4.27%
112,000 $11.4 Million
Q4 2020

Feb 16, 2021

BUY
$66.66 - $111.74 $5.03 Million - $8.44 Million
75,500 Added 181.93%
117,000 $11.6 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $1.9 Million - $3.02 Million
41,500 New
41,500 $3 Million
Q4 2018

Feb 14, 2019

SELL
$12.32 - $24.38 $616,000 - $1.22 Million
-50,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$18.82 - $28.96 $941,000 - $1.45 Million
50,000 New
50,000 $1.2 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.